Search for: "Andrew D. Grant" Results 21 - 40 of 1,224
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Feb 2024, 6:30 am by Guest Blogger
” It was taken for granted. [read post]
15 Feb 2024, 9:05 pm by Jordan Lassiter
Representative Bill Pascrell (D-NJ) welcomed the Act as a vital measure to safeguard personal information and prevent the misuse of manifest data. [read post]
12 Feb 2024, 1:46 am by Brian Cordery (Bristows)
  The UKIPO refused the application for lack of compliance with Article 3(d) of the SPC Regulation which requires that the MA relied upon for the SPC is the first MA to place the product on the market as a medicinal product. [read post]
Moreover, no SPC examiners shall be appointed from national patent offices that do not examine the Article 3(c) and 3(d) conditions (in contrast to the initial legislative proposals which allowed one examiner from such national patent offices per panel). [read post]
4 Feb 2024, 7:14 am by Simon Holzer (MLL Legal Ltd.)
According to Spirig, the first authorization pursuant to Art. 140b para. 2 Swiss Patent Act (Art. 3(d) EU SPC Regulation) was therefore the authorization granted for the monosubstance sitagliptin on 18 April 2007 and not the authorization subsequently granted for the combination in the fixed-dose formulation on 8 April 2008. [read post]
3 Feb 2024, 2:59 pm by Rebecca Tushnet
Andrew Ventimiglia: signs of pleasure/aesthetic questions: are they reflected in opinions of judges themselves? [read post]
24 Jan 2024, 3:40 am by Katie Cambrook (Bristows)
The SPC application therefore did not satisfy Article 3(d) of the SPC Regulation. [read post]
15 Jan 2024, 11:33 am by Kevin LaCroix
The district court granted the insurers summary judgment motion, holding that the indictment was not a claim within the meaning of the policy and that June 2017 letter from the carriers did not establish Schulman’s right to his expenses in defending against the indictment. [read post]
6 Jan 2024, 1:24 am by Kluwer Patent blogger
’ More on the court in number 6: UPC grants 10x Genomics preliminary injunction, NanoString appeals, a September article analysing the UPC’s decision to grant ‘US biotech company 10x Genomics a preliminary injunction against rival NanoString. [read post]
27 Dec 2023, 5:51 am by Myles Jelf (Bristows)
This could be good news for those who were attracted to the Court’s ability to attack European patents on a supra-national basis beyond the 9 month post-grant window of the EPO, but were afraid such challenges would inevitably invite a wider infringement battle. [read post]
27 Dec 2023, 3:00 am by jonathanturley
That was done by Abraham Lincoln, Andrew Johnson, and Jimmy Carter. [read post]
24 Dec 2023, 3:26 pm by Aaron Moss
In what may be 2023’s most profound work of judicial scholarship, Southern District of New York Judge Andrew L. [read post]
22 Dec 2023, 11:00 am by Cynthia Marcotte Stamer
Nunez identified then-Governor Andrew Cuomo’s March 16, 2020 COVID-related Executive Order as the law allegedly violated by defendants, but later amended her complaint to assert that the violation was OSH Act’s General Duty Clause. [read post]
14 Dec 2023, 4:57 am by Beatrice Yahia
British Defense Minister Grant Schapps said the proj [read post]
11 Dec 2023, 9:05 pm by renholding
Striving to better, oft we mar what’s well — William Shakespeare, King Lear (1606) The Delaware Court of Chancery has, for more than a century, honed unparalleled expertise in a unique body of corporate law based on equity – and is thus adaptable enough to address injustice. [read post]
24 Nov 2023, 12:19 am by Kluwer Patent blogger
I’d like to recite an example from a start-up company that was present on 6 November. [read post]